Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for STRATA Skin Sciences (SSKN) over the last 14 years, with Q3 2025 value amounting to $6.2 million.

  • STRATA Skin Sciences' Accumulated Expenses fell 1874.92% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 million, marking a year-over-year decrease of 1874.92%. This contributed to the annual value of $7.4 million for FY2024, which is 1677.77% up from last year.
  • Per STRATA Skin Sciences' latest filing, its Accumulated Expenses stood at $6.2 million for Q3 2025, which was down 1874.92% from $5.9 million recorded in Q2 2025.
  • In the past 5 years, STRATA Skin Sciences' Accumulated Expenses registered a high of $7.6 million during Q3 2024, and its lowest value of $63000.0 during Q1 2021.
  • Over the past 5 years, STRATA Skin Sciences' median Accumulated Expenses value was $5.5 million (recorded in 2021), while the average stood at $4.0 million.
  • Data for STRATA Skin Sciences' Accumulated Expenses shows a peak YoY increase of 508504.67% (in 2021) and a maximum YoY decrease of 9877.67% (in 2021) over the last 5 years.
  • STRATA Skin Sciences' Accumulated Expenses (Quarter) stood at $6.4 million in 2021, then increased by 2.79% to $6.6 million in 2022, then fell by 3.8% to $6.3 million in 2023, then grew by 16.78% to $7.4 million in 2024, then decreased by 15.67% to $6.2 million in 2025.
  • Its Accumulated Expenses was $6.2 million in Q3 2025, compared to $5.9 million in Q2 2025 and $7.2 million in Q1 2025.